Cargando…
Targeting Herpes Simplex Virus-1 gD by a DNA Aptamer Can Be an Effective New Strategy to Curb Viral Infection
Herpes simplex virus type 1 (HSV-1) is an important factor for vision loss in developed countries. A challenging aspect of the ocular infection by HSV-1 is that common treatments, such as acyclovir, fail to provide effective topical remedies. Furthermore, it is not very clear whether the viral glyco...
Autores principales: | Yadavalli, Tejabhiram, Agelidis, Alex, Jaishankar, Dinesh, Mangano, Kyle, Thakkar, Neel, Penmetcha, Kumar, Shukla, Deepak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686428/ https://www.ncbi.nlm.nih.gov/pubmed/29246315 http://dx.doi.org/10.1016/j.omtn.2017.10.009 |
Ejemplares similares
-
Cultured corneas show dendritic spread and restrict herpes simplex virus infection that is not observed with cultured corneal cells
por: Thakkar, Neel, et al.
Publicado: (2017) -
Emerging Roles of Heparanase in Viral Pathogenesis
por: Thakkar, Neel, et al.
Publicado: (2017) -
Drug-encapsulated carbon (DECON): A novel platform for enhanced drug delivery
por: Yadavalli, Tejabhiram, et al.
Publicado: (2019) -
Zinc oxide tetrapods inhibit herpes simplex virus infection of cultured corneas
por: Duggal, Neil, et al.
Publicado: (2017) -
Current and Emerging Therapies for Ocular Herpes Simplex Virus Type-1 Infections
por: Koganti, Raghuram, et al.
Publicado: (2019)